These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


607 related items for PubMed ID: 1677310

  • 1. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM, Heo DS, Okarma T, Johnson JT, Herberman RB, Whiteside TL.
    Cancer Res; 1991 Aug 01; 51(15):3891-9. PubMed ID: 1677310
    [Abstract] [Full Text] [Related]

  • 2. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL.
    Cancer Res; 1993 Mar 15; 53(6):1461-8. PubMed ID: 8443824
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R.
    Cancer Res; 1990 Apr 15; 50(8):2363-70. PubMed ID: 2107973
    [Abstract] [Full Text] [Related]

  • 4. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
    Okada K, Yasumura S, Muller-Fleckenstein I, Fleckenstein B, Talib S, Koldovsky U, Whiteside TL.
    Cell Immunol; 1997 Apr 10; 177(1):35-48. PubMed ID: 9140094
    [Abstract] [Full Text] [Related]

  • 5. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS, Whiteside TL, Johnson JT, Chen KN, Barnes EL, Herberman RB.
    Cancer Res; 1987 Dec 01; 47(23):6353-62. PubMed ID: 3315186
    [Abstract] [Full Text] [Related]

  • 6. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E, Morales R, Barrera JL, Müeller A, Guzman B, Meneses A, Alfaro G.
    Clin Immunol; 2002 Jan 01; 102(1):37-47. PubMed ID: 11781066
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL.
    J Immunol; 1989 Nov 15; 143(10):3404-11. PubMed ID: 2509557
    [Abstract] [Full Text] [Related]

  • 8. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL.
    Clin Cancer Res; 2004 Jun 01; 10(11):3755-62. PubMed ID: 15173082
    [Abstract] [Full Text] [Related]

  • 9. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ, Norihisa Y, Ortaldo JR.
    J Immunol; 1992 Jan 01; 148(1):55-62. PubMed ID: 1345790
    [Abstract] [Full Text] [Related]

  • 10. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
    Rivoltini L, Gambacorti-Passerini C, Squadrelli-Saraceno M, Grosso MI, Cantù G, Molinari R, Orazi A, Parmiani G.
    Cancer Res; 1990 Sep 01; 50(17):5551-7. PubMed ID: 2386961
    [Abstract] [Full Text] [Related]

  • 11. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K, Sakakura K, Whiteside TL, Furuya N.
    Head Neck; 2007 Feb 01; 29(2):120-7. PubMed ID: 17103408
    [Abstract] [Full Text] [Related]

  • 12. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M, Vinzenz K, Kokoschka EM, Kokoschka R.
    Nat Immun Cell Growth Regul; 1985 Feb 01; 4(6):315-27. PubMed ID: 4088287
    [Abstract] [Full Text] [Related]

  • 13. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H, Dobrenkov K, Iida T, Suzuki M, Ando S, Yamamoto N.
    Anticancer Res; 2005 Feb 01; 25(1A):85-94. PubMed ID: 15816523
    [Abstract] [Full Text] [Related]

  • 14. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 15. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
    Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS.
    Cancer Res; 1991 Aug 15; 51(16):4257-65. PubMed ID: 1868446
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.